The Impact of Low Glycemic Index Nutritional Shake on Glucose Regulation in Overweight and Obese Adults
Completed · Not applicable
Conditions studied: Hyperglycemia, Obesity Prevention
In brief
Low glycemic index nutritional shakes have clinically shown to improve post-prandial glycemic responses in acute laboratory control studies. However, there is limited information on how replacing meals with low-glycemic index shake could impact glucose regulation in free-living adults consuming their own diets. The present study aims to examine the impact of adding the SP Glucose-Assist shake to the breakfast of non-diabetic overweight and obese adults. Subjects: 40 non-diabetic adults aged 25-65 years and body mass index ranging between 25-39 . Protocol: This is going to be a three-week study that will include a one-week self-selected diet, followed by two weeks of a breakfast supplement shake (standard process glucose assist) or control cereal oat breakfast.
Key facts
- Study ID
- NCT06856460
- Run by
- Arizona State University
- People needed
- 46
- Starts
- 2025-03-18
- Expected to finish
- 2026-02-09
- Last updated by the study team
- 2026-02-13
Who can join
Age: 25 and older, up to 65. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Body mass index 25-40
- Eating pattern 3 meals a day
- stable weight for the last 2 months (<5 pounds fluctuation)
- Willing to eat oat cereal for breakfast
- glycated hemoglobin <7%
You may not qualify if…
- glycated hemoglobin >7%
- Body mass index ≤25 or ≥ 40
- Night shifting work
- Atypical meal pattern (not three meals a day or intermittent fasting)
- Thyroid medication
- Bariatric surgery
- Habitual strenuous exercise
- Commuting by bicycle
- Eating disorders
- Use of aspirin during the duration of the study
- Intake of Vit C >60 mg/day during the study
- cancer
- cardiovascular disease
- renal disease
- hepatic disease
- X-ray, MRI or CT appointment during the study duration
- Current infection requiring medication
- Chronic, contagious, infectious diseases such as tuberculosis, Hepatitis A, B, C, or HIV
- Medications of supplements that could affect body weight or appetite (i.e. Ozempic)
- Participating in another study at the same time
Where it is running
- Arizona State University 850 PBC — Phoenix, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.